Biotechnology Value Trading Fund OS LP

Director at CTI BIOPHARMA CORP · on record since Jun 28, 2023
Director at Olema Pharmaceuticals, Inc. · on record since Jun 21, 2023
See explanation of responses at Structure Therapeutics Inc. · on record since Feb 13, 2023
See Explanation of Responses at enGene Therapeutics Inc. · on record since Nov 13, 2023
See Explanation of Responses at POINT Biopharma Global Inc. · on record since Nov 6, 2023
Director at Rain Oncology Inc. · on record since Jan 29, 2024
See Remarks; Former 10% Owner at Rain Oncology Inc. · on record since Apr 27, 2021
See Explanation of Responses at Allakos Inc. · on record since Jan 26, 2024
See Explanation of Responses at Xenon Pharmaceuticals Inc. · on record since Sep 12, 2016
Director at IMMUNIC, INC. · on record since Feb 27, 2026
See Explanation of Responses at IMMUNIC, INC. · on record since Feb 27, 2026
Director at MoonLake Immunotherapeutics · on record since Apr 2, 2026
See Explanation of Responses at MoonLake Immunotherapeutics · on record since Apr 2, 2026
10% owner at INFINITY PHARMACEUTICALS, INC. · on record since Dec 30, 2016
See Explanation of Responses at XOMA Royalty Corp · on record since May 18, 2026
See Explanation of Responses at Cascadian Therapeutics, Inc. · on record since Dec 22, 2015
10% owner at Cascadian Therapeutics, Inc. · on record since Jun 27, 2016
See Explanation of Responses at · on record since Dec 2, 2016
See Explanation of Responses at · on record since Jun 22, 2017
See Explanation of Responses at · on record since Jun 14, 2017
See Explanation of Responses at · on record since May 11, 2017
See Explanation of Responses at · on record since Sep 29, 2017
See Explanation of Responses at · on record since Nov 27, 2017
See Explanation of Responses at · on record since Oct 20, 2017
See Explanation of Responses at · on record since Dec 8, 2017
See Explanation of Responses at · on record since Nov 26, 2018
See Explanation of Responses at · on record since Nov 9, 2018
See Explanation of Responses at · on record since Jul 1, 2019
See Explanation of Responses at · on record since Oct 31, 2019
See Explanation of Responses at · on record since Dec 12, 2019
See Explanation of Responses at · on record since Jan 21, 2020
See Explanation of Responses at · on record since Jun 22, 2020
See Explanation of Responses at · on record since Aug 20, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Dec 28, 2020
See Explanation of Responses at · on record since Nov 20, 2020
See Explanation of Responses at · on record since Nov 8, 2021
See Explanation of Responses at · on record since Jan 10, 2022
See Explanation of Responses at · on record since Feb 7, 2022
See Explanation of Responses at · on record since Jun 27, 2022
See Explanation of Responses at · on record since Jul 21, 2022
See Explanation of Responses at · on record since Dec 22, 2022
Director at · on record since Jan 13, 2023
See Remarks and Footnotes at · on record since Aug 25, 2020
Director at · on record since Jan 9, 2023
10% owner at · on record since Oct 5, 2026

Insider trading activity of Biotechnology Value Trading Fund OS LP

Transactions on record: 100; since Jan 11, 2016

Open-market buys: 73; $70.9M

Open-market sells: 9; $14.6M

Companies traded: 13; last filing Jul 1, 2025

Figures computed from official regulatory filings — .

Companies where Biotechnology Value Trading Fund OS LP has traded

6 tx · $24.3M · Jul 1, 2025
9 tx · $9.1M · Nov 17, 2023
6 tx · $15.6M · Sep 14, 2023
9 tx · May 9, 2023
14 tx · $22.5M · May 20, 2022
6 tx · $2M · May 25, 2021
12 tx · $11M · Dec 11, 2020
3 tx · $4.5M · Jan 21, 2020
15 tx · $2.8M · Dec 11, 2019
3 tx · $1.7M · Dec 4, 2018
3 tx · $5.2M · Jun 1, 2018
6 tx · $2M · Oct 5, 2017
8 tx · $1.2M · Jan 11, 2016

Track record of Biotechnology Value Trading Fund OS LP

Statistical track record

Free account

Open-market buys: 79

Last buy: Jun 30, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Biotechnology Value Trading Fund OS LP

Co-insiders of Biotechnology Value Trading Fund OS LP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	115,783	44.00 USD	$5.1M	conv 34First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	142,604	44.00 USD	$6.3M	conv 38First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	58,780	44.00 USD	$2.6M	conv 30First in 12mo	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	16,143	5.38 USD	$86.8K	conv 19	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	493,337	5.00 USD	$2.5M	conv 23	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	125,909	5.38 USD	$677.4K	conv 19	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	153,693	5.38 USD	$826.9K	conv 18	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	390,507	5.00 USD	$2M	conv 22	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	47,712	5.00 USD	$238.6K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	492,251	3.60 USD	$1.8M	conv 24	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	218,979	3.60 USD	$788.3K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	72,479	3.60 USD	$260.9K	conv 25	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	52,801	9.84 USD	$519.6K	conv 23	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Other	99,556	—	n/a (No price was disclosed in the filing)		SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	677,853	9.84 USD	$6.7M	conv 50Unusual size	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	775,278	9.84 USD	$7.6M	conv 49Unusual size	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	Buy	1,055,445	—	n/a (No price was disclosed in the filing)	conv 64	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	165,950	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	1,609,063	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	Buy	837,146	—	n/a (No price was disclosed in the filing)	conv 65	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	2,028,645	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	252,291	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	2,446,209	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	3,084,090	—	n/a (No price was disclosed in the filing)		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	AwardD (derivative)	16,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	115,783	44.00 USD	$5.1M	conv 34First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	142,604	44.00 USD	$6.3M	conv 38First in 12mo	SEC
Kymera Therapeutics, Inc.Listing on record	Jul 1, 2025	Buy	58,780	44.00 USD	$2.6M	conv 30First in 12mo	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	16,143	5.38 USD	$86.8K	conv 19	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	493,337	5.00 USD	$2.5M	conv 23	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	125,909	5.38 USD	$677.4K	conv 19	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	153,693	5.38 USD	$826.9K	conv 18	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	390,507	5.00 USD	$2M	conv 22	SEC
Repare Therapeutics Inc.Listing unverified	Nov 17, 2023	Buy	47,712	5.00 USD	$238.6K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	492,251	3.60 USD	$1.8M	conv 24	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	218,979	3.60 USD	$788.3K	conv 21	SEC
Repare Therapeutics Inc.Listing unverified	Nov 3, 2023	Buy	72,479	3.60 USD	$260.9K	conv 25	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	52,801	9.84 USD	$519.6K	conv 23	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Other	99,556	—	n/a (No price was disclosed in the filing)		SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	677,853	9.84 USD	$6.7M	conv 50Unusual size	SEC
Olema Pharmaceuticals, Inc.Listing on record	Sep 14, 2023	Buy	775,278	9.84 USD	$7.6M	conv 49Unusual size	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	Buy	1,055,445	—	n/a (No price was disclosed in the filing)	conv 64	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	165,950	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	1,609,063	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	Buy	837,146	—	n/a (No price was disclosed in the filing)	conv 65	SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	2,028,645	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	252,291	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	2,446,209	—	n/a (No price was disclosed in the filing)		SEC
Eledon Pharmaceuticals, Inc.Listing on record	May 9, 2023	BuyD (derivative)	3,084,090	—	n/a (No price was disclosed in the filing)		SEC